Pittman Corinne A, Roura Raúl, Price Carrie, Lin Frank R, Marrone Nicole, Nieman Carrie L
Cochlear Center for Hearing & Public Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.
Howard University College of Medicine, Washington, DC.
JAMA Otolaryngol Head Neck Surg. 2021 Jul 1;147(7):656-662. doi: 10.1001/jamaoto.2021.0550.
Although the National Institutes of Health (NIH) mandated the inclusion and reporting of women and racial or ethnic minority groups in NIH-funded research in 1993, little is known regarding the representation of women and racial or ethnic minority groups in trials that investigate hearing loss management.
To assess sex and racial/ethnic representation in US-based clinical trials of hearing loss management in an adult population.
Pertinent studies were identified using search strategies in PubMed, Embase, and ClinicalTrials.gov.
Our search strategy yielded 6196 studies. We included prospective studies that were written in English, performed in the US, and evaluated hearing loss management in adults, including amplification devices, such as hearing aids or assistive listening devices, cochlear implants, aural rehabilitation, and therapeutics. Given its prevalence, only studies that addressed bilateral sensorineural hearing loss were included.
Data from 125 studies were extracted. The Preferred Reporting Items for Systematic Reviews and Meta-analyses diagram for systematic reviews was used for abstracting data. The guidelines were applied using independent extraction by multiple observers.
Among 125 clinical studies performed from January 1990 to July 2020 regarding hearing loss management, only 16 (12.8%) reported race/ethnicity, and 88 (70.4%) reported sex. Of the 16 studies that reported race/ethnicity, only 5 included more than 30% non-White representation. Among the 88 articles that reported sex, 44 (35.2%) reported more than 45% female representation. While the mean number of participants included in the observed trials was 80 (range, 7-644), the median number of participants from racial or ethnic minority groups in studies that reported race/ethnicity was 9 (range, 1-77), and a median of 12 female participants were included in studies with a numerical breakdown by sex. A mean of 41% (range, 1.55%-77.5%) of participants were female among studies that reported sex, and a mean of 30% (range, 1.96%-100%) of participants were from racial or ethnic minority groups among the 16 studies that reported race/ethnicity. Reporting of race/ethnicity varied substantially by funding source and journal type, while reporting by sex differed only by journal type.
Studies investigating hearing loss management do not adequately reflect the US population. A closer examination of the inclusion of diverse adults in clinical research associated with hearing health may work to ameliorate disparities and contribute to the development of tailored interventions that address the needs of an increasingly diverse US population.
尽管美国国立卫生研究院(NIH)在1993年就规定在由NIH资助的研究中要纳入并报告女性以及种族或族裔少数群体,但对于调查听力损失管理的试验中女性和种族或族裔少数群体的代表性情况,人们了解甚少。
评估美国针对成年人群体的听力损失管理临床试验中的性别和种族/族裔代表性情况。
使用PubMed、Embase和ClinicalTrials.gov中的检索策略确定相关研究。
我们的检索策略共检索到6196项研究。我们纳入了以英文撰写、在美国开展且评估成人听力损失管理的前瞻性研究,包括放大装置,如助听器或辅助听力设备、人工耳蜗、听觉康复和治疗方法。鉴于双侧感音神经性听力损失的普遍性,仅纳入了针对该情况的研究。
提取了125项研究的数据。采用系统评价和Meta分析的首选报告项目图进行数据提取。由多名观察者独立提取数据并应用这些指南。
在1990年1月至2020年7月期间开展的125项关于听力损失管理的临床研究中,只有16项(12.8%)报告了种族/族裔情况,88项(70.4%)报告了性别情况。在报告种族/族裔情况的16项研究中,只有5项非白人代表性超过30%。在报告性别的88篇文章中,44项(35.2%)报告女性代表性超过45%。观察到的试验中纳入的参与者平均数量为80名(范围为7 - 644名),报告了种族/族裔情况的研究中,来自种族或族裔少数群体的参与者中位数为9名(范围为1 - 77名),按性别细分的研究中女性参与者中位数为12名。在报告性别的研究中,参与者平均41%为女性(范围为1.55% - 77.5%),在报告种族/族裔情况的16项研究中,参与者平均30%来自种族或族裔少数群体(范围为1.96% - 100%)。种族/族裔情况的报告因资金来源和期刊类型差异很大,而性别的报告仅因期刊类型不同而有差异。
调查听力损失管理的研究未能充分反映美国人口情况。更密切地审视在与听力健康相关的临床研究中纳入不同成年人的情况,可能有助于改善差异,并为制定满足日益多样化的美国人口需求的针对性干预措施做出贡献。